Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Background: Hypersensitivity or Leukocytoclastic vasculitis (LCV) following the COVID-19 vaccination has been reported rarely all over the world. LCV can be induced by certain factors such as infections, autoimmune disorders, malignancy, or some classes of drugs. Case presentation: A 32-year-old man, who was a known case of seizure disorder from his childhood presented to the department of dermatology with itchy red lesions on extremities and abdomen for the past 1 month. He explains a history of COVID-19 vaccination 1-month back and experienced itching on his lower limbs on the same day at night. A gradual worsening of the condition was observed day by day. He was hospitalized and diagnosed as LCV through clinical and laboratory findings. Conclusion: This case highlights a temporal association with the event of vaccination. The causality assessment showed an indeterminate causal association to LCV with COVID-19 Vaccination.

Cite

CITATION STYLE

APA

Sebastian, J., Mathew, M., Sharsty, V., & Ramesh, M. (2022). Leukocytoclastic Vasculitis Following COVID-19 Vaccination: A Case Report. Hospital Pharmacy, 57(4), 564–567. https://doi.org/10.1177/00185787211067379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free